Management of Leptomeningeal Metastases in Non-Oncogene Addicted Non-Small Cell Lung Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2018.00278
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

P1.01-19 Efficacy of Tyrosine Kinase Inhibitors in EGFR Mutated Non-Small Cell Lung Cancer With Leptomeningeal Metastases

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Response of Leptomeningeal Metastases in EGFR-Mutated Non-Small-Cell Lung Cancer to Afatinib in the Absence of Radiotherapy

Case Reports in Oncological Medicine
Oncology
2019English

Management of Brain Metastases in Epidermal Growth Factor Receptor Mutant Non-Small-Cell Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2018English

Surgical Management of Oligometastatic Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Skeletal Related Events in Non-Small Cell Lung Cancer With Bone Metastases

Palliative Care Research
2010English

Non-Small Cell Lung Cancer

English

Survival of Patients With Non-Small Cell Lung Cancer and Brain Metastases

Clinical Oncology
Nuclear MedicineRadiologyImagingOncology
2011English

Development of Leptomeningeal Carcinomatosis During a Marked Response of Brain Metastases to Pembrolizumab in a Patient With Non-Small-Cell Lung Cancer

Annals of Oncology
MedicineOncologyHematology
2018English

When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?

Current Treatment Options in Oncology
OncologyPharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy